Low Volume Metastatic Castration Sensitive Prostate Cancer clinical trials

Explore recruiting low volume metastatic castration sensitive prostate cancer clinical trials.

Recruiting low volume metastatic castration sensitive prostate cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Low Volume Metastatic Castration Sensitive Prostate Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Apa/Enza short study (Shortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-volume metastatic castration-sensitive prostate cancer: a randomized nationwide trial

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Low Volume Metastatic Castration Sensitive Prostate Cancer trials by city

Low Volume Metastatic Castration Sensitive Prostate Cancer in Toronto Low Volume Metastatic Castration Sensitive Prostate Cancer in Vancouver Low Volume Metastatic Castration Sensitive Prostate Cancer in Montreal Low Volume Metastatic Castration Sensitive Prostate Cancer in Calgary Low Volume Metastatic Castration Sensitive Prostate Cancer in Edmonton Low Volume Metastatic Castration Sensitive Prostate Cancer in Ottawa Low Volume Metastatic Castration Sensitive Prostate Cancer in Winnipeg Low Volume Metastatic Castration Sensitive Prostate Cancer in Quebec City Low Volume Metastatic Castration Sensitive Prostate Cancer in Hamilton Low Volume Metastatic Castration Sensitive Prostate Cancer in Kitchener Low Volume Metastatic Castration Sensitive Prostate Cancer in London Low Volume Metastatic Castration Sensitive Prostate Cancer in Halifax Low Volume Metastatic Castration Sensitive Prostate Cancer in New York Low Volume Metastatic Castration Sensitive Prostate Cancer in Los Angeles Low Volume Metastatic Castration Sensitive Prostate Cancer in Chicago Low Volume Metastatic Castration Sensitive Prostate Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease